Searching for smart, safe news you can TRUST?
Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
President Trump had some harsh words for the pharmaceutical industry and pharmacy benefit managers in his speech Friday, but investors bought stocks instead of the vague promises Trump and his administration made to bring down drug prices.
The bottom line: The major pharmaceutical and biotech indices, like the S&P and Nasdaq that include companies like Pfizer and Regeneron, all traded up Friday. The stock prices of Express Scripts and CVS, two leading PBMs, also went up, indicating the industry and investors don't anticipate a major shake-up.